NCT03545334
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +21 more
- Locations
-
- Inselspital, University Hospital Bern, University of Bern Bern, Canton of Bern, Switzerland
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
5,051 public trials
1,181 recruiting studies
Adenocarcinoma trial results
NCT00286013
- Conditions
- Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
- Locations
-
- Erasme University Hospital Brussels, Belgium
- Jules Bordet Institute Brussels, Belgium
- University Hospital Ghent Ghent, Belgium
- CHU Sart-Tilman Liège, Belgium
Completed
Adjuvant Capecitabine vs Gemcitabine Plus Cisplatin in Resected Extrahepatic Cholangiocarcinoma
NCT03079427
- Conditions
- Adenocarcinoma, Adjuvant Chemotherapy, Biliary Tract Cancer, +13 more
- Locations
-
- Asan Medical Center, University of Ulsan College of Medicine Seoul, South Korea
NCT03079440
- Conditions
- Adenocarcinoma, Capecitabine, Carcinoma, +10 more
- Locations
-
- Asan Medical Center, University of Ulsan College of Medicine Seoul, South Korea
NCT04310709
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Bundang CHA Hospital Seongnam, South Korea
- Asan Medical Center Seoul, South Korea
- Samsung Medical Center Seoul, South Korea
NCT02013492
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Diseases, +42 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT03233360
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Royal Prince Alfred Hospital Camperdown, New South Wales, Australia
- Royal Adelaide Hospital Adelaide, South Australia, Australia
- Flinders Medical Centre Bedford Park, South Australia, Australia
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
Completed
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
NCT02643303
- Conditions
- Adenocarcinoma, Bladder Cancer, Breast Cancer, +65 more
- Locations
-
- Research Facility Atlanta, Georgia, United States
- Research Facility Lebanon, New Hampshire, United States
- Research Facility Buffalo, New York, United States
- Research Facility New York, United States
NCT03517488
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
- Locations
-
- Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
- UCLA Hematology-Oncology Clinic (Westwood) Los Angeles, California, United States
- University of California San Diego Moores Cancer Center San Diego, California, United States
- University of California San Francisco Medical Center San Francisco, California, United States
Completed
Nonmyeloablative Allogeneic Transplant
NCT01272817
- Conditions
- Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Adenocarcinoma, +91 more
- Locations
-
- Scripps Green Hospital La Jolla, California, United States